Compromise CBD (v1) Grow Difficulty: Medium

From: 25.00

Parents: Undisclosed
Type: 50% Indica / 50% Sativa
Taste: Earthy / Herbal / Dried fruit
Effect: Non-psychoactive relaxation
Flowering time: 8-10 Weeks

  • + / –0.29%THC
  • + / –5.2%CBD
  • + / –0.01%CBN
  • + / –0.11%THCV
  • + / –0.25%CBG
Strain Information Reviews

Strain information

Amsterdam Genetics’ First Version CBD Seeds

Discover Amsterdam Genetics’ first CBD strain to be released as feminized seeds. Compromise CBD v1 is still being developed. But as we’re eager to receive feedback from home growers, we decided to release a LIMITED AMOUNT of affordable seeds of this strain onto the market. 

Compromise CBD v1 is a CBD dominant cannabis strain, testing at roughly 5,3 % CBD and 0,3 % THC. Respectively providing a 1:20  THC:CBD ratio. Thanks to a low amount of the psychoactive compound THC, Compromise CBD v1 is perfectly suited for medicinal cannabis users. As it will provide relief, without getting consumers ‘high’ or ‘stoned’. 

Compromise CBD v1 seeds offer regular-sized cannabis buds with an earthy and herbaceous taste; and subtle hints of dried fruit. Though we rely on YOUR FEEDBACK for a more detailed description of the plant’s grow characteristics in different environments. The effect when smoked can best be described as a light relaxation of the body and mind, without the heavy sedation as that of THC-dominant cannabis.

As said, Compromise CBD v1 is ideal for medicinal use, for example with pain, depression and fatigue. Though this CBD strain is also suitable for lighter recreational use and can be used as an alternative for tobacco in joints / spliffs. Combined with high-THC cannabis, Compromise CBD v1 will provide indica-leaning effects. Making it perfect to ‘take the edge’ off of sativa-dominant, sometimes ‘jumpy’, cannabis strains.



Medicinal Benefits

Stress Relief
Depression Relief
Pain Relief
Fatigue Relief
Headaches Relief




There are no reviews yet.

Be the first to review “Compromise CBD (v1)”

Your email address will not be published. Required fields are marked *